The invention provides compounds capable of acting as antagonists at cannabanoid receptors according to the following formula: Such compounds may be used to treat conditions for which the cannabinoid receptor system has been implicated, such as obesity, liver disease, diabetes, pain, and inflammation.
Peripherally restricted diphenyl purine derivatives
Maitra, R., Fulp, A., Zhang, Y., & Seltzman, H. (2015). Peripherally restricted diphenyl purine derivatives. (U.S. Patent No. 9,187,408). http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=9187480.PN.&OS=PN/9187480&RS=PN/9187480
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Treatment preferences among patients with mild-to-moderate atopic dermatitis
Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Spatiotemporal analysis exploring the effect of law enforcement drug market disruptions on overdose, Indianapolis, Indiana, 2020-2021